Literature DB >> 20593004

Tachykinins and Neurokinin Receptors in Bone Marrow Functions: Neural-Hematopoietic Link.

Tilman E Klassert1, Shyam A Patel, Pranela Rameshwar.   

Abstract

After many decades of neuropeptide research, advances in the field of tachykinins have considerably increased and shown their implications in several physiological processes. In this review we focus on the role of the tachykinins in the regulation of hematopoietic functions. Evidence has shown that neural control of this process is emerging as a significant category in hematopoietic modulation. In the context of this regulation, we discuss the existence of a complex network involving the neurokinin receptors, tachykinins and cytokines. This network is tightly regulated by each of its components.

Entities:  

Year:  2010        PMID: 20593004      PMCID: PMC2893333          DOI: 10.2147/jrlcr.s6509

Source DB:  PubMed          Journal:  J Receptor Ligand Channel Res        ISSN: 1178-699X


  109 in total

1.  Synergy between the RE-1 silencer of transcription and NFkappaB in the repression of the neurotransmitter gene TAC1 in human mesenchymal stem cells.

Authors:  Steven J Greco; Sergey V Smirnov; Raghav G Murthy; Pranela Rameshwar
Journal:  J Biol Chem       Date:  2007-08-20       Impact factor: 5.157

Review 2.  The significance of substance P in physiological and malignant haematopoiesis.

Authors:  Michal Nowicki; Danuta Ostalska-Nowicka; Beata Kondraciuk; Bogdan Miskowiak
Journal:  J Clin Pathol       Date:  2006-12-15       Impact factor: 3.411

3.  Noradrenergic and peptidergic innervation of the mouse femur bone marrow.

Authors:  Z Tabarowski; K Gibson-Berry; S Y Felten
Journal:  Acta Histochem       Date:  1996-11       Impact factor: 2.479

4.  Neurokinin-1 receptor resensitization precedes receptor recycling.

Authors:  V J Bennett; S A Perrine; M A Simmons
Journal:  J Pharmacol Exp Ther       Date:  2005-03-11       Impact factor: 4.030

Review 5.  An overview of new and novel pharmacotherapies for use in traumatic brain injury.

Authors:  R Vink; A J Nimmo; I Cernak
Journal:  Clin Exp Pharmacol Physiol       Date:  2001-11       Impact factor: 2.557

6.  Neurokinin B induces oedema formation in mouse lung via tachykinin receptor-independent mechanisms.

Authors:  Andrew D Grant; Roksana Akhtar; Norma P Gerard; Susan D Brain
Journal:  J Physiol       Date:  2002-09-15       Impact factor: 5.182

7.  Differences in the expression of neurokinin receptor in neural and bone marrow mesenchymal cells: implications for neuronal expansion from bone marrow cells.

Authors:  P S Bandari; J Qian; G Yehia; H P Seegopaul; J S Harrison; P Gascon; H Fernandes; P Rameshwar
Journal:  Neuropeptides       Date:  2002-02       Impact factor: 3.286

Review 8.  Involvement of adipogenic potential of human bone marrow mesenchymal stem cells (MSCs) in osteoporosis.

Authors:  J Pablo Rodríguez; Pablo Astudillo; Susana Ríos; Ana María Pino
Journal:  Curr Stem Cell Res Ther       Date:  2008-09       Impact factor: 3.828

Review 9.  Transcription factors responsive to cAMP.

Authors:  P Sassone-Corsi
Journal:  Annu Rev Cell Dev Biol       Date:  1995       Impact factor: 13.827

10.  Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment.

Authors:  Olaia Naveiras; Valentina Nardi; Pamela L Wenzel; Peter V Hauschka; Frederic Fahey; George Q Daley
Journal:  Nature       Date:  2009-06-10       Impact factor: 49.962

View more
  4 in total

1.  Constitutive Expression of Inducible Cyclic Adenosine Monophosphate Early Repressor (ICER) in Cycling Quiescent Hematopoietic Cells: Implications for Aging Hematopoietic Stem Cells.

Authors:  Steven J Greco; Ghassan Yehia; Julius A Potian; Carlos A Molina; Pranela Rameshwar
Journal:  Stem Cell Rev Rep       Date:  2017-02       Impact factor: 5.739

2.  Human acute myeloid leukemia cells express Neurokinin-1 receptor, which is involved in the antileukemic effect of Neurokinin-1 receptor antagonists.

Authors:  A Molinos-Quintana; P Trujillo-Hacha; J I Piruat; J A Bejarano-García; E García-Guerrero; J A Pérez-Simón; Miguel Muñoz
Journal:  Invest New Drugs       Date:  2018-05-02       Impact factor: 3.850

3.  An indirect role for oncomir-519b in the expression of truncated neurokinin-1 in breast cancer cells.

Authors:  Peter Navarro; Shakti H Ramkissoon; Simant Shah; Jacqueline M Park; Raghav G Murthy; Shyam A Patel; Steven J Greco; Pranela Rameshwar
Journal:  Exp Cell Res       Date:  2012-09-12       Impact factor: 3.905

4.  Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in endometrial cancer.

Authors:  Naghmeh Gharaee; Leila Pourali; Amir Hossein Jafarian; Seyed Isaac Hashemy
Journal:  Mol Biol Rep       Date:  2018-09-17       Impact factor: 2.316

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.